KLK4 and prostate neoplasm: Of note, KLK4 is known to be expressed as a variety of isoforms [12], with the full length protein (254 amino acids long) showing the potential to be a better biomarker of prostate tumour cells than the commonly expressed shorter isoform (205 amino acids) [11].